Trove
Sign In Sign Up

Michael Cella

Person
Mentions
186
Relationships
12
Events
1
Documents
89
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
12 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Cowen
Employee
18 Very Strong
38
View
person Cowen
Employment affiliation
11 Very Strong
19
View
person Cowen
Professional
7
3
View
person Cowen
Employment internal distribution
7
2
View
person Cowen
Employment internal
6
2
View
person Cowen
Client
6
1
View
person Cowen
Professional employment
6
2
View
person Cowen
Employment
5
1
View
person Cowen and Company
Employment affiliation
5
1
View
person Cowen and Company, LLC
Employee
5
1
View
person Cowen
Employment recipient
5
1
View
person Cowen and Company
Employee
1
1
View
Date Event Type Description Location Actions
2019-02-25 N/A Publication of Cowen Collaborative Insights report. N/A View

HOUSE_OVERSIGHT_024833.jpg

This document is page 17 of a financial research report produced by Cowen and Company, dated February 25, 2019. The content focuses on 'Synthetic Cannabis,' detailing the differences between endogenous, phyto-, and synthetic cannabinoids, and includes a table (Figure 9) outlining the medicinal roles of specific compounds like THC and CBD. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, the visible text contains no direct references to Jeffrey Epstein or his associates.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024832.jpg

This document is page 16 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes U.S. hemp production, providing a statistical table of planted acres by state for 2017 and 2018, showing a significant increase in total acreage. The text discusses economic challenges for the hemp CBD market, including supply saturation and seed costs. While marked with a 'HOUSE_OVERSIGHT' Bates number, this specific page contains no direct mention of Jeffrey Epstein, his associates, or victims; it appears to be part of a larger financial document production.

Market research report / financial analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024831.jpg

A page from a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. The document analyzes agricultural economics, specifically comparing corn and soybean margins per acre and detailing the growth of the industrial hemp market in Kentucky under the KDA pilot program. It provides statistical data on acreage, growers, and market shifts toward CBD production between 2014 and 2019. The document bears a House Oversight Bates stamp, suggesting it was part of a document production to Congress.

Financial research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024829.jpg

This document is page 13 of a Cowen Collaborative Insights financial report dated February 25, 2019. It analyzes the economics of CBD hemp cultivation, citing budget models from the University of Kentucky, and discusses yields, returns, and variable costs associated with 'plasticulture' farming. The document bears a House Oversight Bates stamp, but contains no direct references to Jeffrey Epstein, Ghislaine Maxwell, or typical associates in the text provided.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024828.jpg

A page from a Cowen 'Collaborative Insights' report dated February 25, 2019, analyzing the industrial hemp and CBD market. The text details agricultural requirements including soil testing, irrigation, pesticide restrictions, and costs associated with clones versus seeds. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as part of a congressional investigation, likely into financial practices or specific business entities.

Industry research report / financial analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024827.jpg

A page from a Cowen Collaborative Insights research report dated February 25, 2019, authored by Neivert. It details the legal status of CBD hemp cultivation following the 2018 Farm Bill, contrasting it with the 2014 Farm Bill, and outlines cultivation practices and the lack of standardized research. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, though the specific content on this page is strictly related to agricultural industry analysis.

Financial research report / industry analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024825.jpg

A page from a Cowen and Company financial research report dated February 25, 2019, analyzing the U.S. CBD market. The report projects a $16 billion revenue opportunity by 2025, breaking down the market into sectors such as nutraceuticals ($6.4bn), topicals ($4bn), and beverages ($2.4bn). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was produced as part of a Congressional investigation, potentially related to financial records, though no specific Epstein connection is visible in the text of this specific page.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024824.jpg

This document is page 8 of a Cowen market research report dated February 25, 2019, analyzing the market size and consumer demographics of CBD products. It details survey results from January 2019 showing a 6.9% usage rate, skewing towards younger demographics (18-34), and identifies tinctures as the dominant delivery mechanism. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (often associated with financial probes into banks connected to Jeffrey Epstein), the content of this specific page is strictly financial market analysis regarding CBD and tobacco/vaping products.

Financial market research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024823.jpg

This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024822.jpg

This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.

Financial research report (table of contents)
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024821.jpg

This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.

Market research report / financial analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024820.jpg

This document is page 4 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the market for cannabinoids (CBD), focusing on synthetic biology production methods, laboratory testing opportunities for life science companies, and the perspectives of drug retailers and insurance payors regarding coverage and sales. The document bears a 'HOUSE_OVERSIGHT_024820' Bates stamp, indicating it was part of a production to the House Oversight Committee, likely related to financial investigations.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024819.jpg

A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.

Financial research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024817.jpg

This document is the cover page of a Cowen Equity Research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. The report provides market analysis and projections for the CBD industry, predicting $16 billion in sales by 2025, and highlights specific stocks (WEED, TLRY, TPB). While the content is strictly financial research, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024817,' indicating it was collected as part of a House Oversight Committee investigation.

Equity research report / financial analysis
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
28
Total
28

Cowen Collaborative Insights

From: Cowen Research
To: Michael Cella

Research report distribution intended for michael.cella@cowen.com

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis of corn, soybeans, and hemp production economics.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and Epidiolex efficacy/safety data.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and CBD clinical trials.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding CBD/Cannabis regulations in Europe.

Report distribution
2019-02-25
Communication Source

Consumer Products Market Sizing (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Market research report regarding CBD usage statistics and market sizing.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Financial analysis of the U.S. Beauty and CBD Beauty markets.

Report distribution
2019-02-25
Communication Source

Collaborative Insights: Vapor

From: Cowen
To: Michael Cella

Market analysis of CBD vapor and e-cigarette sales projections.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule providers distributed to michael.cella@cowen.com

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market analysis of CBD confection and bar products, including price segmentation.

Report distribution
2019-02-25
Communication Source

Valuation Methodology and Risks

From: Cowen
To: Michael Cella

Investment report distribution restricted to michael.cella@cowen.com

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights Report

From: Cowen
To: Michael Cella

Analysis of Epidiolex drug trials and investor sentiment regarding efficacy with/without clobazam.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial analysis of cannabis and tobacco companies.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights - CBD Market Analysis

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule pricing and demographic usage statistics.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis of CBD gummy pricing and packaging.

Report distribution
2019-02-25
Communication Source

Report Distribution

From: Cowen
To: Michael Cella

This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report regarding cannabis market partnerships.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry report on Synthetic Biology Cannabinoid Companies.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding hemp and CBD in textiles.

Report distribution
2019-02-25
Communication Source

Collaborative Insights - Topicals

From: Cowen
To: Michael Cella

Markey analysis of CBD topicals distributed to internal employee.

Report distribution
2019-02-25
Communication Source

Global CBD Landscape (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Analysis of international drug conventions and WHO recommendations regarding CBD regulation.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry analysis regarding CBD-infused textiles and partnerships.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Financial rating history charts for GW Pharmaceuticals, Tilray, and Turning Point Brands.

Report distribution
2019-02-25
Communication Source

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search